Anthony N. Corps
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anthony N. Corps has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Graham P. Riley
School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK
5 shared publications B. L. Hazleman
3 shared publicationsA. H. N. Robinson
2 shared publicationsM. L. Costa
2 shared publications- Stephen K. Smith
University of Cambridge
2 shared publications T. Movin
2 shared publications
Latest Publications
- Open Access
- 11 October 2005
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (3) , 291-294
Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy
Objectives. To determine the expression of mRNA encoding the proteoglycans aggrecan, versican, biglycan and decorin in mid-tendon samples of chronic painful Achilles tendinopathy and ruptured Achilles tendons, compared with normal tendons. Methods. Total RNA isolated from frozen tendon samples (14 normal, 13 painful, 14 ruptured) was assayed by relative quantitative reverse transcription polymerase chain reaction for aggrecan, versican, biglycan and decorin mRNA, normalized using 18S rRNA. Differences between sample groups were tested by univariate analysis of variance with age as co-variate. Results. In normal tendon samples expression of each of the proteoglycan mRNA decreased with increasing age. Decorin mRNA was the most highly-expressed of the proteoglycan mRNA, while versican mRNA expression was higher (3.8-fold) than that of aggrecan. In painful tendinopathy both aggrecan and biglycan mRNA expression increased (more than 10-fold and 5-fold, respectively) compared with normal tendon samples, but levels of versican and decorin mRNA were not significantly changed. In ruptured tendons the levels of aggrecan, biglycan and versican mRNA were not changed compared with normal tendon samples, but decorin mRNA decreased markedly. Conclusions. Increased aggrecan and biglycan mRNA expression in painful tendinopathy resembles the pattern in fibrocartilaginous regions of tendon, and may reflect an altered mechanical environment at the site of the lesion. Increased aggrecan mRNA expression may underlie the increase in glycosaminoglycan observed in painful tendinopathy.
- 11 October 2005
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (3) , 291-294
Open AccessIncreased expression of aggrecan and biglycan mRNA in Achilles tendinopathy
Objectives. To determine the expression of mRNA encoding the proteoglycans aggrecan, versican, biglycan and decorin in mid-tendon samples of chronic painful Achilles tendinopathy and ruptured Achilles tendons, compared with normal tendons. Methods. Total RNA isolated from frozen tendon samples (14 normal, 13 painful, 14 ruptured) was assayed by relative quantitative reverse transcription polymerase chain reaction for aggrecan, versican, biglycan and decorin mRNA, normalized using 18S rRNA. Differences between sample groups were tested by univariate analysis of variance with age as co-variate. Results. In normal tendon samples expression of each of the proteoglycan mRNA decreased with increasing age. Decorin mRNA was the most highly-expressed of the proteoglycan mRNA, while versican mRNA expression was higher (3.8-fold) than that of aggrecan. In painful tendinopathy both aggrecan and biglycan mRNA expression increased (more than 10-fold and 5-fold, respectively) compared with normal tendon samples, but levels of versican and decorin mRNA were not significantly changed. In ruptured tendons the levels of aggrecan, biglycan and versican mRNA were not changed compared with normal tendon samples, but decorin mRNA decreased markedly. Conclusions. Increased aggrecan and biglycan mRNA expression in painful tendinopathy resembles the pattern in fibrocartilaginous regions of tendon, and may reflect an altered mechanical environment at the site of the lesion. Increased aggrecan mRNA expression may underlie the increase in glycosaminoglycan observed in painful tendinopathy.
- Open Access
- 7 September 2005
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 44 (12) , 1514-1517
Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells
Objectives. Fluoroquinolone antibiotics may cause tendon pain and rupture. We reported previously that the fluoroquinolone ciprofloxacin potentiated interleukin (IL)-1β-stimulated expression of matrix metalloproteinases (MMP)-3 and MMP-1 in human tendon-derived cells. We have now tested additional fluoroquinolones and investigated whether they have a similar effect on expression of MMP-13. Methods. Tendon cells were incubated for two periods of 48 h with or without fluoroquinolones and IL-1β. Total ribonucleic acid (RNA) was assayed for MMP messenger RNA by relative quantitative reverse transcriptase polymerase chain reaction, with normalization for glyceraldehyde-3-phosphate dehydrogenase mRNA. Samples of supernatant medium were assayed for MMP output by activity assays. Results. MMP-13 was expressed by tendon cells at lower levels than MMP-1, and was stimulated typically 10- to 100-fold by IL-1β. Ciprofloxacin, norfloxacin and ofloxacin each reduced both basal and stimulated expression of MMP-13 mRNA. In contrast, ciprofloxacin and norfloxacin increased basal and IL-1β-stimulated MMP-1 mRNA expression. Both the inhibition of MMP-13 and the potentiation of MMP-1 expression by fluoroquinolones were accompanied by corresponding changes in IL-1β-stimulated MMP output. The non-fluorinated quinolone nalidixic acid had lesser or no effects. Conclusions. Fluoroquinolones show contrasting effects on the expression of the two collagenases MMP-1 and MMP-13, indicating specific effects on MMP gene regulation.
- 7 September 2005
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 44 (12) , 1514-1517
Open AccessContrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells
Objectives. Fluoroquinolone antibiotics may cause tendon pain and rupture. We reported previously that the fluoroquinolone ciprofloxacin potentiated interleukin (IL)-1β-stimulated expression of matrix metalloproteinases (MMP)-3 and MMP-1 in human tendon-derived cells. We have now tested additional fluoroquinolones and investigated whether they have a similar effect on expression of MMP-13. Methods. Tendon cells were incubated for two periods of 48 h with or without fluoroquinolones and IL-1β. Total ribonucleic acid (RNA) was assayed for MMP messenger RNA by relative quantitative reverse transcriptase polymerase chain reaction, with normalization for glyceraldehyde-3-phosphate dehydrogenase mRNA. Samples of supernatant medium were assayed for MMP output by activity assays. Results. MMP-13 was expressed by tendon cells at lower levels than MMP-1, and was stimulated typically 10- to 100-fold by IL-1β. Ciprofloxacin, norfloxacin and ofloxacin each reduced both basal and stimulated expression of MMP-13 mRNA. In contrast, ciprofloxacin and norfloxacin increased basal and IL-1β-stimulated MMP-1 mRNA expression. Both the inhibition of MMP-13 and the potentiation of MMP-1 expression by fluoroquinolones were accompanied by corresponding changes in IL-1β-stimulated MMP output. The non-fluorinated quinolone nalidixic acid had lesser or no effects. Conclusions. Fluoroquinolones show contrasting effects on the expression of the two collagenases MMP-1 and MMP-13, indicating specific effects on MMP gene regulation.
- 1 June 2004
- Published by Elsevier in Matrix Biology
- Vol. 23 (3) , 163-169
Inhibition of interleukin-1β-stimulated collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin gallate ester
- 1 June 2004
- Published by Elsevier in Matrix Biology
- Vol. 23 (3) , 163-169
Inhibition of interleukin-1β-stimulated collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin gallate ester
- Open Access
- 1 June 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (8) , 969-972
Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies
Objectives. Versican is the principal large proteoglycan expressed in mid-tendon, but its role in tendon pathology is unknown. Our objective was to define the expression of versican isoform splice variant messenger ribonucleic acid (mRNA) in normal Achilles tendons, in chronic painful tendinopathy and in ruptured tendons.
- 1 June 2004
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (8) , 969-972
Open AccessVersican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies
Objectives. Versican is the principal large proteoglycan expressed in mid-tendon, but its role in tendon pathology is unknown. Our objective was to define the expression of versican isoform splice variant messenger ribonucleic acid (mRNA) in normal Achilles tendons, in chronic painful tendinopathy and in ruptured tendons.
- Open Access
- 8 November 2002
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (11) , 3034-3040
Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin‐1β in human tendon‐derived cells
Objective: To determine whether the fluoroquinolone antibiotic ciprofloxacin, which can cause tendon pain and rupture in a proportion of treated patients, affects the expression of matrix metalloproteinases (MMPs) in human tendon‐derived cells in culture.Methods: Cell cultures were derived from 6 separate tendon explants, and were incubated in 6‐well culture plates for 2 periods of 48 hours each, with ciprofloxacin (or DMSO in controls) and interleukin‐1β (IL‐1β), alone and in combination. Samples of supernatant medium from the second 48‐hour incubation were assayed for MMPs 1, 2, and 3 by Western blotting. RNA was extracted from the cells and assayed for MMP messenger RNA (mRNA) by semiquantitative reverse transcription–polymerase chain reaction, with normalization for GAPDH mRNA.Results: Unstimulated tendon cells expressed low or undetectable levels of MMP‐1 and MMP‐3, and substantial levels of MMP‐2. IL‐1β induced a substantial output of both MMP‐1 and MMP‐3 into cell supernatants, reflecting increases (typically 100‐fold) in MMP mRNA, but had only minor effects on MMP‐2 expression. Ciprofloxacin had no detectable effect on MMP output in unstimulated cells. Preincubation with ciprofloxacin potentiated IL‐1β–stimulated MMP‐3 output, reflecting a similar effect on MMP‐3 mRNA expression. Ciprofloxacin also potentiated IL‐1β–stimulated MMP‐1 mRNA expression, but did not potentiate the output of MMP‐1, and had no significant effects on MMP‐2 mRNA expression or output.Conclusion: Ciprofloxacin can selectively enhance MMP expression in tendon‐derived cells. Such effects might compromise tendon microstructure and integrity.
- 8 November 2002
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (11) , 3034-3040
Open AccessCiprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin‐1β in human tendon‐derived cells
Objective: To determine whether the fluoroquinolone antibiotic ciprofloxacin, which can cause tendon pain and rupture in a proportion of treated patients, affects the expression of matrix metalloproteinases (MMPs) in human tendon‐derived cells in culture.Methods: Cell cultures were derived from 6 separate tendon explants, and were incubated in 6‐well culture plates for 2 periods of 48 hours each, with ciprofloxacin (or DMSO in controls) and interleukin‐1β (IL‐1β), alone and in combination. Samples of supernatant medium from the second 48‐hour incubation were assayed for MMPs 1, 2, and 3 by Western blotting. RNA was extracted from the cells and assayed for MMP messenger RNA (mRNA) by semiquantitative reverse transcription–polymerase chain reaction, with normalization for GAPDH mRNA.Results: Unstimulated tendon cells expressed low or undetectable levels of MMP‐1 and MMP‐3, and substantial levels of MMP‐2. IL‐1β induced a substantial output of both MMP‐1 and MMP‐3 into cell supernatants, reflecting increases (typically 100‐fold) in MMP mRNA, but had only minor effects on MMP‐2 expression. Ciprofloxacin had no detectable effect on MMP output in unstimulated cells. Preincubation with ciprofloxacin potentiated IL‐1β–stimulated MMP‐3 output, reflecting a similar effect on MMP‐3 mRNA expression. Ciprofloxacin also potentiated IL‐1β–stimulated MMP‐1 mRNA expression, but did not potentiate the output of MMP‐1, and had no significant effects on MMP‐2 mRNA expression or output.Conclusion: Ciprofloxacin can selectively enhance MMP expression in tendon‐derived cells. Such effects might compromise tendon microstructure and integrity.
- 1 December 1997
- Vol. 77 (6) , 607-14
Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.
Vascular endothelial growth factor (VEGF) is an angiogenic factor secreted by various tumors, including epithelial tumors of the ovary, and is involved in tumor progression and maintenance. The significance and function of other members of the VEGF family in the ovary has not yet been elucidated. In the present study, we have defined the expression of mRNA encoding VEGF-B, VEGF-C, and placenta growth factor (PIGF), compared with that of VEGF mRNA, in normal ovary and a range of ovarian epithelial tumors. Analysis by reverse transcription-PCR indicated that mRNA encoding VEGF (isoforms 121 and 165), VEGF-B (isoforms 167 and 186), and VEGF-C, but not PIGF, were present in all ovarian tissues examined. By in situ hybridization, neither VEGF-C nor PIGF transcripts were detected in any of the samples. The expression pattern of VEGF-B mRNA was generally similar to that of VEGF mRNA, in that transcripts were readily detected in the epithelial cells of all histologic types of ovarian carcinoma, but could not be detected in normal or benign tumor epithelium. Specific differences in the expression of the two genes were noted in areas of tumor necrosis, in which the expression of VEGF mRNA, but not VEGF-B mRNA, was further enhanced, and in a sample in which VEGF-B mRNA was strongly expressed in tumor-associated macrophages that did not hybridize with the riboprobe to VEGF mRNA. These results imply that a second member of the VEGF family, VEGF-B, may play a significant role in the angiogenesis, progression, and maintenance of ovarian carcinomas.
- 1 December 1997
- Vol. 77 (6) , 607-14
Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.
Vascular endothelial growth factor (VEGF) is an angiogenic factor secreted by various tumors, including epithelial tumors of the ovary, and is involved in tumor progression and maintenance. The significance and function of other members of the VEGF family in the ovary has not yet been elucidated. In the present study, we have defined the expression of mRNA encoding VEGF-B, VEGF-C, and placenta growth factor (PIGF), compared with that of VEGF mRNA, in normal ovary and a range of ovarian epithelial tumors. Analysis by reverse transcription-PCR indicated that mRNA encoding VEGF (isoforms 121 and 165), VEGF-B (isoforms 167 and 186), and VEGF-C, but not PIGF, were present in all ovarian tissues examined. By in situ hybridization, neither VEGF-C nor PIGF transcripts were detected in any of the samples. The expression pattern of VEGF-B mRNA was generally similar to that of VEGF mRNA, in that transcripts were readily detected in the epithelial cells of all histologic types of ovarian carcinoma, but could not be detected in normal or benign tumor epithelium. Specific differences in the expression of the two genes were noted in areas of tumor necrosis, in which the expression of VEGF mRNA, but not VEGF-B mRNA, was further enhanced, and in a sample in which VEGF-B mRNA was strongly expressed in tumor-associated macrophages that did not hybridize with the riboprobe to VEGF mRNA. These results imply that a second member of the VEGF family, VEGF-B, may play a significant role in the angiogenesis, progression, and maintenance of ovarian carcinomas.
- Open Access
- 26 September 1997
- Published by Wiley in International Journal of Cancer
- Vol. 73 (1) , 151-155
Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-MET
A proportion of ovarian carcinomas markedly overexpress the proto‐oncogene c‐met, which encodes the receptor for hepatocyte growth factor (HGF). HGF may either stimulate or inhibit the multiplication of its target cells, and may also promote motogenesis and morphogenesis. In this study, we established that the ovarian carcinoma‐derived cell‐line SK‐OV‐3 expressed about 20‐fold higher levels of c‐met protein than are expressed by a second line, CH1. This enabled us to test functional consequences of high‐level expression of c‐met in ovarian carcinoma cells. The addition of HGF to attached cultures of SK‐OV‐3 cells caused a change to a motile phenotype, that was evident after 4–6 hr and affected essentially all of the cells by 24 hr. When HGF was placed in the lower compartment of a migration chamber, it induced a 17‐fold increase in the migration of SK‐OV‐3 cells to the lower surface of the filter. Finally, HGF stimulated the incorporation of [3H]‐thymidine by cultures of SK‐OV‐3 cells incubated in medium containing either low (0.2%) or full (10%) FCS. None of these responses were obtained when HGF was added to CH1 cells. We conclude that high levels of c‐met expression in ovarian cancer cells may lead to a range of responses to HGF that would promote tumour growth and dissemination. Int. J. Cancer 73:151–155, 1997.
- 26 September 1997
- Published by Wiley in International Journal of Cancer
- Vol. 73 (1) , 151-155
Open AccessHepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-MET
A proportion of ovarian carcinomas markedly overexpress the proto‐oncogene c‐met, which encodes the receptor for hepatocyte growth factor (HGF). HGF may either stimulate or inhibit the multiplication of its target cells, and may also promote motogenesis and morphogenesis. In this study, we established that the ovarian carcinoma‐derived cell‐line SK‐OV‐3 expressed about 20‐fold higher levels of c‐met protein than are expressed by a second line, CH1. This enabled us to test functional consequences of high‐level expression of c‐met in ovarian carcinoma cells. The addition of HGF to attached cultures of SK‐OV‐3 cells caused a change to a motile phenotype, that was evident after 4–6 hr and affected essentially all of the cells by 24 hr. When HGF was placed in the lower compartment of a migration chamber, it induced a 17‐fold increase in the migration of SK‐OV‐3 cells to the lower surface of the filter. Finally, HGF stimulated the incorporation of [3H]‐thymidine by cultures of SK‐OV‐3 cells incubated in medium containing either low (0.2%) or full (10%) FCS. None of these responses were obtained when HGF was added to CH1 cells. We conclude that high levels of c‐met expression in ovarian cancer cells may lead to a range of responses to HGF that would promote tumour growth and dissemination. Int. J. Cancer 73:151–155, 1997.